A mechanistic review highlights new evidence that systemic insulin resistance exacerbates neurodegenerative changes seen in Alzheimer’s disease , bridging metabolic and neurocognitive research. Targeting insulin resistance might represent a future avenue for risk mitigation in at-risk populations. To read more Click Here ##Reference## Wang S, Shi Y, Xin R, et al. Insulin resistance: a bridge between metabolic syndrome and Alzheimer’s disease.
Front Endocrinol. 2025;16:1614006.## In your experience, what is the strongest modifiable risk factor for Alzheimer’s progression? a) Vascular risk management b) Glycemic control c) Weight loss d) Cognitive training
